Bausch Health Companies (BHC) Interest Expenses (2009 - 2026)

Bausch Health Companies has disclosed Interest Expenses across 18 years of filings, most recently posting $402.0 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $402.0 million, up 21.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 22.96% YoY), and the FY2025 annual result was $1.6 billion, up 15.56% from the prior year.
• Interest Expenses came in at $402.0 million for Q1 2026 at Bausch Health Companies, up from $397.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $465.0 million in Q2 2025 to a low of $307.0 million in Q4 2022.
• The 5-year median for Interest Expenses is $355.0 million (2024), against an average of $363.9 million.
• Across the five-year window, Interest Expenses decreased 22.2% in 2023 and soared 32.86% in 2025, its largest moves.
• Bausch Health Companies' Interest Expenses stood at $307.0 million in 2022, then climbed by 18.24% to $363.0 million in 2023, then fell by 7.16% to $337.0 million in 2024, then climbed by 17.8% to $397.0 million in 2025, then increased by 1.26% to $402.0 million in 2026.
• The last three Interest Expenses figures came in at $402.0 million (Q1 2026), $397.0 million (Q4 2025), and $412.0 million (Q3 2025), per Business Quant data.